Skip to main content

Table 1 The association between UCHL1 expression with clinical pathologic characteristics in the TMA cohort

From: The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation

Clinical pathologic characteristics Case No. UCHL1 expression P
low high
Total cases   33 31  
Gender
 Male 35 17 18 P = 0.5989
 Female 29 16 13  
Age at diagnosis
 < 18 months 20 11 9 P = 0.7106
 > 18 months 44 22 22  
stage
 1, 2, 3 41 20 21 P = 0.3535
 4, 4S 23 13 10  
Primary site
 Retroperitoneum 29 15 14 Pa = 0.9312
 Postmediastinum 8 4 4  
 NA 27 14 13  
Bone marrow metastasis
 Positive 7 3 4 Pb = 0.6054
 Negative 26 14 12  
 NA 31 16 15  
  1. NA Not available. Analysis by chi-square criterion test
  2. aDenotes significant difference between retroperitoneum and postmediastinum
  3. bDenotes significant difference between positive and negative bone marrow metastasis